ANVISA import authorization for medicinal cannabis into Brazil
Import / Export Verified 2026-04-20
Workflow steps
Import Intent
Brazil is the LARGEST Latin American medical cannabis market. Two distinct import pathways exist: personal use (simpler) and commercial sale (requires full ANVISA product registration).
ANVISA import authorization
Personal use: doctor letter + online form
Commercial: ANVISA product registration required
Personal use or commercial?
ANVISA provides two distinct pathways. Personal use authorization is simpler and faster. Commercial import requires full product registration.
Personal Use Import — Simplified pathway
Doctor letter + ANVISA online form. Processing approximately 30 days. For individual patient import only — not for resale.
Commercial import requires ANVISA product registration (see Product Registration workflow). Only ANVISA-registered products may be imported for commercial sale.
ANVISA product registration (see product-reg)
ANVISA import authorization per shipment
GMP certificate from manufacturing country
Brazilian sponsor/importer entity
Brazilian Customs Entry
Customs clearance with ANVISA import authorization. ANVISA and Receita Federal (Brazilian IRS/Customs) both involved.
ANVISA import authorization (original)
Commercial invoice and shipping documents
GMP certificate
ANVISA may conduct sample inspection
Import Cleared ✓
Cannabis product cleared for entry into Brazil. Personal use: delivered to patient. Commercial: distributed to licensed pharmacies.